Overview
Optimum Misoprostol Dose Prior to Office Hysteroscopy
Status:
Completed
Completed
Trial end date:
2013-04-01
2013-04-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
Misoprostol is an effective agent for cervical priming before office hysteroscopy, vaginal route is the best, optimum dose not yet known.Phase:
Phase 3Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Cairo UniversityTreatments:
Misoprostol
Criteria
Inclusion Criteria:- Female patient pre- or postmenopausal undergo office hysteroscopy.
- Age: from 20 to 60.
- BMI between 18 and 30.
Exclusion Criteria:
- PID or
- Heavy uterine bleeding
- Cervical malignancy.
- Symptoms suggestive of endometriosis .
- Any cervical abnormality such as pinhole cervix that would obviate passage of a
catheter through the cervix.